A citation-based method for searching scientific literature

Ewelina Kulikowski, Brooke D Rakai, Norman C W Wong. Med Res Rev 2021
Times Cited: 45



Qiming Duan, Sarah McMahon, Priti Anand, Hirsh Shah, Sean Thomas, Hazel T Salunga, Yu Huang, Rongli Zhang, Aarathi Sahadevan, Madeleine E Lemieux, Jonathan D Brown, Deepak Srivastava, James E Bradner, Timothy A McKinsey, Saptarsi M Haldar. Sci Transl Med 2017
Times Cited: 141




List of shared articles



Times cited

Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases.
Ewelina Kulikowski, Brooke D Rakai, Norman C W Wong. Med Res Rev 2021
45

Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis.
Rong Fu, Shi-Jia Zu, Yan-Jun Liu, Jia-Cheng Li, Wen-Zhen Dang, Li-Ping Liao, Li-Ping Liu, Pan-Yu Chen, He-Ming Huang, Kang-Hui Wu,[...]. Bioengineered 2022
2

Dual-target inhibitors of bromodomain and extra-terminal proteins in cancer: A review from medicinal chemistry perspectives.
Lu Feng, Guan Wang, Yi Chen, Gu He, Bo Liu, Jie Liu, Cheng-Ming Chiang, Liang Ouyang. Med Res Rev 2022
8

Breaking boundaries: Pan BETi disrupt 3D chromatin structure, BD2-selective BETi are strictly epigenetic transcriptional regulators.
Laura M Tsujikawa, Olesya A Kharenko, Stephanie C Stotz, Brooke D Rakai, Christopher D Sarsons, Dean Gilham, Sylwia Wasiak, Li Fu, Michael Sweeney, Jan O Johansson,[...]. Biomed Pharmacother 2022
1

Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis.
Zhangxu He, Haomiao Jiao, Qi An, Xin Zhang, Dan Zengyangzong, Jiale Xu, Hongmin Liu, Liying Ma, Wen Zhao. Acta Pharm Sin B 2022
2

Epigenetics-based therapeutics for myocardial fibrosis.
Xuping Li, Ying Yang, Sixuan Chen, Jiuyao Zhou, Jingyan Li, Yuanyuan Cheng. Life Sci 2021
12

N-terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cells.
Joshua A Nord, Sarah L Wynia-Smith, Alyssa L Gehant, Rachel A Jones Lipinski, Aaron Naatz, Inmaculada Rioja, Rab K Prinjha, John A Corbett, Brian C Smith. Front Endocrinol (Lausanne) 2022
0

Genome-wide CRISPR-Cas9 screens identify mechanisms of BET bromodomain inhibitor sensitivity.
David Estoppey, Gabi Schutzius, Christian Kolter, Adrian Salathe, Tiffany Wunderlin, Amandine Meyer, Florian Nigsch, Tewis Bouwmeester, Dominic Hoepfner, Susan Kirkland. iScience 2021
1

Selective inhibitors of bromodomain BD1 and BD2 of BET proteins modulate radiation-induced profibrotic fibroblast responses.
Chun-Shan Liu, Inmaculada Rioja, Ali Bakr, Marlon R Veldwijk, Elena Sperk, Carsten Herskind, Dieter Weichenhan, Rab K Prinjha, Christoph Plass, Peter Schmezer,[...]. Int J Cancer 2022
0